Stocktoria

Cardio Diagnostics Holdings, Inc. CDIO

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2021-11-23 · LEI

Cardio Diagnostics Holdings, Inc. statistics & valuation

Market cap$5.9M
P / B0.9×
Net margin-43832.5%
Return on equity-93.2%
FCF margin-39893.1%
Return on capital-90.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-68862.20% -490630.00% -49087.80% -24028.20% -43832.50% 20212022202320242025
Gross margin (%)
20212022202320242025
Operating margin (%)
-68862.20% -478784.30% -42440.40% -23977.90% -43737.50% 20212022202320242025
Return on equity (%)
-58.10% -108.40% -283.20% -87.70% -93.20% 20212022202320242025
Shares outstanding
1.2M 9.5M 20.5M 1.5M 1.8M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-56.30% -74.60% -187.70% -79.00% -83.70% 20212022202320242025
Free cash flow margin (%)
-36612.00% -14926.50% -39893.10% 20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$0.53 -$1.51 -$0.66 -$9.35 -$3.71 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Operating margin-43737.5%-23977.9%-42440.4%-478784.3%-68862.2%
Net margin-43832.5%-24028.2%-49087.8%-490630.0%-68862.2%
FCF margin-39893.1%-14926.5%-36612.0%——
Return on assets-83.7%-79.0%-187.7%-74.6%-56.3%
Return on equity-93.2%-87.7%-283.2%-108.4%-58.1%
Current ratio9.7913.923.293.026.46

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.